GEN Exclusives

More »

GEN News Highlights

More »
Jan 28, 2010

Repligen Strikes Five-Year Extension to Supply Protein A to GE Healthcare

  • Repligen entered into a five-year supply agreement with GE Healthcare for recombinant Protein A, a consumable used in the manufacture of mAbs. This agreement provides for Repligen to continue to be a strategic supplier to GE Healthcare through 2014.

    GE Healthcare sells chromatography products that incorporate Repligen's recombinant Protein A to the biopharmaceutical industry for the manufacture of mAbs.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »